UAB outsources its revenue-producing antibodies to the Birmingham company SouthernBiotech
University of Alabama at BirminghamIn a move to maintain revenue and expand opportunities to produce and license new monoclonal antibodies, UAB has outsourced its selection of marketable monoclonal immunoreagents and hybridomas — the cells that produce monoclonal antibodies — to the Birmingham-based SouthernBiotech.